Intelligent Bio Solutions is a small medical technology company that sells the Intelligent Fingerprinting Drug Screening System (IFP System), a non-invasive, fingerprint sweat-based drug screening platform. The IFP System works by pressing each finger onto a disposable cartridge for a few seconds, collecting sweat from ten fingerprints; the cartridge is then inserted into a portable handheld reader that delivers results in under ten minutes. The system screens for opioids, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The company's primary customers are employers in safety-critical industries — construction, transportation, mining, and manufacturing — as well as drug rehabilitation and judicial organizations, concentrated in the UK with additional presence in Europe, the Middle East, and Australia. The business model is built around recurring consumable sales: each test requires a single-use disposable cartridge, and the one-time reader hardware purchase locks customers into ongoing cartridge purchases. Revenue scales with the number of active readers deployed and testing frequency. The company manufactures cartridges and readers at its Cambridge, UK facility and has installed over 1,000 readers across more than 450 customers. Intelligent Bio Solutions' growth strategy centers on U.S. market entry, for which it filed an FDA 510(k) submission in December 2024, alongside geographic expansion through distributors in the Middle East and Asia Pacific, and product development to add fentanyl and oxycodone to the screening panel.